<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04774614</url>
  </required_header>
  <id_info>
    <org_study_id>22 10 20</org_study_id>
    <nct_id>NCT04774614</nct_id>
  </id_info>
  <brief_title>Shade Match, Marginal Adaptation and Patient Satisfaction of VITA ENAMIC multiColor Versus IPS e.Max CAD Veneers</brief_title>
  <official_title>Shade Match, Marginal Adaptation and Patient Satisfaction of VITA ENAMIC multiColor Versus IPS e.Max CAD Anterior Laminate Veneers (Randomized Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is assumed that there will be no difference in shade match, marginal adaptation and&#xD;
      patient satisfaction between VITA ENAMIC multiColor and IPS e.max CAD anterior laminate&#xD;
      veneers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study settings:&#xD;
&#xD;
      This study will be carried out on patients enrolled from the Outpatient clinic in fixed&#xD;
      prosthodontics clinic, Faculty of Oral and Dental Medicine, Cairo University.&#xD;
&#xD;
      Participant timeline:&#xD;
&#xD;
      The patient will be treated in visits designated as follows:&#xD;
&#xD;
        1. st Visit: Preoperative records, face-to-face adherence reminder session, clinical,&#xD;
           radiographic examination and primary impression for diagnostic cast construction.&#xD;
&#xD;
        2. nd Visit: Teeth preparation, secondary impression and temporary restoration.&#xD;
&#xD;
        3. rd Visit : Try in&#xD;
&#xD;
        4. th Visit: Placement and permanent cementation of the final restoration. Shade match,&#xD;
           marginal adaptation and patient satisfaction will be evaluated immediately after&#xD;
           cementation&#xD;
&#xD;
      Data collection methods&#xD;
&#xD;
      Primary outcome (Shade match) will be assessed by using Modified United State Public Health&#xD;
      Service Criteria (Modified USPHS Criteria).&#xD;
&#xD;
      Secondary outcomes:&#xD;
&#xD;
      Marginal adaptation will be assessed by modified USPHS criteria. Patient's satisfaction will&#xD;
      be assessed using nominal scores (non-acceptable, acceptable, good and excellent).&#xD;
&#xD;
      Data management:&#xD;
&#xD;
      All data will be entered electronically in an Excel sheet. Patient files are to be stored in&#xD;
      numerical order in a secured place.&#xD;
&#xD;
      Statistical methods:&#xD;
&#xD;
        -  All Data will be collected, checked, revised, tabulated and entered into the computer.&#xD;
&#xD;
        -  Data will be analyzed using IBM advance statistics (Statistics package for social&#xD;
           sciences) version 21 (SPSS inc, Chicago, IL)&#xD;
&#xD;
        -  Categorical data will be described as numbers and percentage&#xD;
&#xD;
        -  Data will be explored for normality using Kolmogrov-smirnov test and Shapiro-wilk test&#xD;
&#xD;
        -  Comparison between two groups for normally distributed numeric variables will be done by&#xD;
           Mann-Whitney test. An equivalence limit will be tested.&#xD;
&#xD;
        -  A P-value less than or equal to 0.05 will be considered statistically significant. All&#xD;
           tests will be two tailed.&#xD;
&#xD;
      Data monitoring:&#xD;
&#xD;
      Monitoring The main supervisor is responsible of data monitoring if harms arise, interim&#xD;
      analysis will be done.&#xD;
&#xD;
      Harms Any adverse effect like pain or even failure will be recorded, documented and treated.&#xD;
&#xD;
      Audit Auditing of the study design will be done by the evidence-based committee of the&#xD;
      faculty of Oral and Dental medicine at Cairo University.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>shade match</measure>
    <time_frame>immediately after restoration delivery</time_frame>
    <description>measured by Modified United States Public Health Service criteria (USPHS criteria). Score Alpha (A): matches tooth, Bravo (B): acceptable mismatch, Charlie (C): unacceptable mismatch</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>marginal adaptation</measure>
    <time_frame>immediately after restoration delivery</time_frame>
    <description>measured by Modified United States Public Health Service criteria (USPHS criteria). Score Alpha (A): no catch with explorer , Bravo (B):explorer catches , Charlie (C): explorer penetrates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>immediately after restoration delivery</time_frame>
    <description>measure by Questionnaire (Scores are non-acceptable, acceptable, good and excellent).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Shade Match</condition>
  <arm_group>
    <arm_group_label>VITA ENAMIC multiColor anterior laminate veneers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>IPS e.max CAD anterior laminate veneers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>anterior laminate veneers</intervention_name>
    <description>VITA ENAMIC multiColor</description>
    <arm_group_label>IPS e.max CAD anterior laminate veneers</arm_group_label>
    <arm_group_label>VITA ENAMIC multiColor anterior laminate veneers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients aged 18-55 years, are able to read and sign the informed consent document.&#xD;
&#xD;
          2. Patients who are physically and psychologically able to tolerate conventional&#xD;
             restorative procedures.&#xD;
&#xD;
          3. Patients with no active periodontal or pulpal diseases and have teeth with good&#xD;
             restorations.&#xD;
&#xD;
          4. Patients with complaints related to the esthetics in the upper or lower teeth (e.g.&#xD;
             discoloration, fracture that does not involve more than 50% enamel loss, mild&#xD;
             malposition)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients in the growth stage with partially erupted teeth.&#xD;
&#xD;
          2. Patient with fractured teeth of more than 50% enamel loss.&#xD;
&#xD;
          3. Patients with poor oral hygiene.&#xD;
&#xD;
          4. Patient with non-vital teeth.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nancy Sayed Abdel Aziz Abdel Aal Khalil</investigator_full_name>
    <investigator_title>PhD candidate</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

